| 发明名称 |
THE USE OF SULINDAC AND/OR ITS METABOLITE AS ADJUVANT TREATMENT FOR COLON CANCER IN HUMANS |
| 摘要 |
<p>The use of sulindac and/or its metabolite in combination with cytostatic drugs as adjuvant treatment for colon cancer in humans. The cytostatic is selected from a group including: 5-f luorouracil, capecitabine, oxaliplatin, leucovorin and irinotecan and/or their combinations.</p> |
| 申请公布号 |
WO2010095965(A1) |
申请公布日期 |
2010.08.26 |
| 申请号 |
WO2010PL00015 |
申请日期 |
2010.02.18 |
| 申请人 |
FARMA-PROJEKT SP. Z 0.0.;SPLAWINSKI, JACEK;FIIS, SYLWIA |
发明人 |
SPLAWINSKI, JACEK;FIIS, SYLWIA |
| 分类号 |
A61K31/192;A61K31/282;A61K31/505;A61K45/06;A61P35/00 |
主分类号 |
A61K31/192 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
